Clinically Advanced Pheochromocytomas and Paragangliomas: A Comprehensive Genomic Profiling Study

Clinically Advanced Pheochromocytomas and Paragangliomas: A Comprehensive Genomic Profiling Study

Patients with clinically advanced paragangliomas (CA-Para) and pheochromocytomas (CA-Pheo) have limited surgical or systemic treatments. We used comprehensive genomic profiling (CGP) to compare genomic alterations (GA) in CA-Para and CA-Pheo to identify potential therapeutic targets. Eighty-three CA...

Full description

Bibliographic Details
Main Authors: Gennady Bratslavsky, Ethan S. Sokol, Michael Daneshvar, Andrea Necchi, Oleg Shapiro, Joseph Jacob, Nick Liu, Tom S. Sanford, Ruben Pinkhasov, Hanan Goldberg, Jonathan K. Killian, Shakti Ramkissoon, Eric A. Severson, Richard S. P. Huang, Natalie Danziger, Mehdi Mollapour, Jeffrey S. Ross, Karel Pacak
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
pheochromocytoma
paraganglioma
comprehensive genomic profiling
genomic alterations
Online Access:https://www.mdpi.com/2072-6694/13/13/3312

Internet

https://www.mdpi.com/2072-6694/13/13/3312

Similar Items